Rene Thonhofer. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdalimumabAnti-Inflammatory Agents, Non-Steroidal/therapeutic useAntibodies, Monoclonal, Humanized/therapeutic useAntirheumatic Agents/therapeutic useAzathioprine/therapeutic useBiomarkers/bloodC-Reactive Protein/analysisCyclosporine/therapeutic useDrug Therapy, CombinationEtanerceptHumansImmunoglobulin G/bloodImmunoglobulin G/therapeutic useImmunoglobulin M/bloodInterleukin 1 Receptor Antagonist Protein/therapeutic useMaleMethotrexate/therapeutic usePain MeasurementPrednisone/therapeutic useReceptors, Tumor Necrosis Factor/therapeutic useSchnitzler Syndrome/bloodSchnitzler Syndrome/drug therapy
Substances: See more » Anti-Inflammatory Agents, Non-SteroidalAntibodies, Monoclonal, HumanizedAntirheumatic AgentsBiomarkersImmunoglobulin GImmunoglobulin MInterleukin 1 Receptor Antagonist ProteinReceptors, Tumor Necrosis FactorCyclosporineC-Reactive ProteinAdalimumabAzathioprineEtanerceptPrednisoneMethotrexate
Year: 2010 PMID: 21125280 DOI: 10.1007/s00296-010-1681-1
Source DB: PubMed Journal: Rheumatol Int ISSN: 0172-8172 Impact factor: 2.631